Physician

Radha M Rao, M.D.

According to 2025 Medicare claims, Radha Rao, M.D. (NPI: 1699746016) practices hematology/oncology in the Sioux City, IA-NE-SD market, with the plurality of this provider's patient population coming from Woodbury, IA. This provider's primary affiliated billing organization is SIOUXLAND REGIONAL CANCER CENTER (NPI: 1114904604; TIN: 421411233) and primary practice location at 51101-1733. Rao is affiliated with the Prairie Vista Care Organization (ACO ID: A3578), Bryan Health Connect ACO, LLC (ACO ID: A4573), and Avera Prairie View ACO (ACO ID: A4692), participating under the MSSP model.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 474 traditional Medicare patients, billed 63,119 HCPCS/CPT codes, and received $1,412,033 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 298 prescription claims across 120 beneficiaries totaling $470,539 in drug costs, led by Imbruvica (Ibrutinib). 2021 DME data shows 12 claims. Open Payments data shows 19 records totaling $385. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,816,917 to $1,412,033. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,524,935 to $470,539. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,988 to $960.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,127	142,499	$1,816,917
2016	1,112	96,488	$1,540,804
2017	1,016	115,382	$1,685,479
2018	818	106,618	$1,895,841
2019	618	87,726	$1,485,794
2020	258	30,294	$472,485
2021	319	41,542	$727,835
2022	443	34,718	$650,684
2023	355	36,034	$634,711
2024	474	63,119	$1,412,033

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	332	2,090	$1,524,935
2016	350	2,242	$2,472,788
2017	308	1,810	$1,980,219
2018	286	1,370	$1,530,118
2019	152	542	$597,995
2020	87	194	$61,608
2021	76	170	$379,701
2022	122	296	$865,401
2023	91	198	$493,291
2024	120	298	$470,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	85	$29,587
2016	12	61	$23,688
2017	14	59	$19,385
2018	N/R	28	$5,481
2019	N/R	23	$1,690
2020	N/R	12	$892
2021	N/R	12	$960
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	201	230	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	246	282	$12
80053	Blood test, comprehensive group of blood chemicals	374	487	$10
36415	Insertion of needle into vein for collection of blood sample	317	416	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	413	559	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	13	364	$212,182
Anastrozole	Anastrozole	43	2,208	$501
Letrozole	Letrozole	20	1,440	$280
Hydroxyurea	Hydroxyurea	19	922	$218
Dexamethasone	Dexamethasone	25	158	$168

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$385	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Radha M. Rao, M.D.?

Tedicare shows public-source Medicare data for Radha M. Rao, M.D. (NPI 1699746016), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Radha M. Rao, M.D. have ACO affiliation data?

Radha M. Rao, M.D. is shown with ACO affiliation data for Prairie Vista Care Organization (MSSP, ACO ID A3578), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), and Avera Prairie View ACO (MSSP, ACO ID A4692).

What billing organization is linked to Radha M. Rao, M.D.?

Radha M. Rao, M.D. is linked to SIOUXLAND REGIONAL CANCER CENTER (billing NPI 1114904604) in the available physician profile data.

Does Radha M. Rao, M.D. have Open Payments data?

Radha M. Rao, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.